|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2008-10-7
|
|
pubmed:abstractText |
Hypertrophic cardiomyopathy (HCM) is often accompanied by atrial fibrillation (AF) due to diastolic dysfunction, elevated left atrial pressure, and enlargement. Although catheter ablation for drug-refractory AF is an effective treatment, the efficacy in HCM remains to be established.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1540-8167
|
|
pubmed:author |
pubmed-author:AsirvathamSamuel JSJ,
pubmed-author:BradyPeter APA,
pubmed-author:BunchT JaredTJ,
pubmed-author:ChaYong-MeiYM,
pubmed-author:FriedmanPaul APA,
pubmed-author:HaroldsonJanis MJM,
pubmed-author:MonahanKristi HKH,
pubmed-author:MungerThomas MTM,
pubmed-author:OmmenSteve RSR,
pubmed-author:PackerDouglas LDL,
pubmed-author:PowellBrian DBD,
pubmed-author:ReaRobert FRF,
pubmed-author:ShenWin-KuangWK
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1009-14
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
|
|
pubmed:affiliation |
Division of Cardiovascular Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA.
|
|
pubmed:publicationType |
Journal Article
|
